Home
Services
About Us
- Company Profile
- Our Team
Facilities
*New*
Resources
Careers
News and Events
Contact

Select Page

Midsize Biopharmaceutical Company

August 3, 2026

“Great people, excellent chemistry, strong collaboration and exceptional execution”

NJ BIOPHARMACEUTICALS

Where Chemistry Grows



Email NJ Bio

info@njbio.com



NJ Bio Headquarters

350 Carter Rd
Princeton, NJ 08540



Our Bristol Facility

310 George Patterson Boulevard,
Bristol, PA 19007

QUICK LINKS

Home

About Us

Facilities

Careers

News and Events

Contact Us / Request Quote

FIND US ON

© NJ Bio, Inc.

Parent Item 1
- Sub-Menu-1a
  - Sub-Menu-2a
Parent Item 2
- Sub-Menu-1b
  - Sub-Menu-2b
Parent Item 3
- Sub-Menu-1c
  - Sub-Menu-2c

Mechanism of Action
Bioconjugation Methods
Types of Linkers
Cytotoxin Selection
Linker-Payload Selection
Mechanism of ADC Toxicity
ADCs Approved and in Clinical Trials
ADC Conjugation Technologies
Discontinued ADC Projects
Notable Business Deal, Mergers & Acquisitions in The ADC Space

Mechanism of Action
Bioconjugation Methods
Types of Linkers
Cytotoxin Selection
Linker-Payload Selection
Mechanism of ADC Toxicity
ADCs Approved and in Clinical Trials
ADC Conjugation Technologies
Discontinued ADC Projects
Notable Business Deal, Mergers & Acquisitions in The ADC Space

Mechanism of Action
Bioconjugation Methods
Types of Linkers
Cytotoxin Selection
Linker-Payload Selection
Mechanism of ADC Toxicity
ADCs Approved and in Clinical Trials
ADC Conjugation Technologies
Discontinued ADC Projects
Notable Business Deal, Mergers & Acquisitions in The ADC Space

Article Overview